IPG
47
-5
VNO
52
6
CHD
54
-2
IBM
55
4
CNX
52
2
V
48
-2
LUV
50
-2
BMY
43
-5
CFG
62
-2
TMO
36
-4
RL
65
5
MOS
40
-2
MU
50
3
NKE
21
3
PYPL
33
2
AMT
55
3
HRB
56
2
ZBH
59
-3
GD
52
3
NVDA
42
2
IPG
47
-5
VNO
52
6
CHD
54
-2
IBM
55
4
CNX
52
2
V
48
-2
LUV
50
-2
BMY
43
-5
CFG
62
-2
TMO
36
-4
RL
65
5
MOS
40
-2
MU
50
3
NKE
21
3
PYPL
33
2
AMT
55
3
HRB
56
2
ZBH
59
-3
GD
52
3
NVDA
42
2
Financhill
Back

ClearPoint Neuro Stock Predictions

Apple's Drop in iPhone Sales Opens the Door for New Entrant

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35

CLPT
ClearPoint Neuro

Last Price:
$13.28
Seasonality Move:
-7.58%

7 Day Trial

ALL ACCESS PASS

$ 7

AI Marketing Shift Is Happening–Act Before It's Too Late!

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.

ClearPoint Neuro Stock Forecast

  • Over the next 52 weeks, ClearPoint Neuro has on average historically risen by 25.9% based on the past 12 years of stock performance.
  • ClearPoint Neuro has risen higher in 4 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
  • Is ClearPoint Neuro Stock Undervalued?
    The current ClearPoint Neuro [CLPT] share price is $13.09. The Score for CLPT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • CLPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will ClearPoint Neuro Stock Go Up Next Year?

  • Over the next 52 weeks, ClearPoint Neuro has on average historically risen by 25.9% based on the past 12 years of stock performance.

ClearPoint Neuro Stock Rating

Sell
35
ClearPoint Neuro (CLPT) is a Sell

Is ClearPoint Neuro overpriced?

  • ClearPoint Neuro has risen higher in 4 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

ClearPoint Neuro Stock Price History

Is CLPT stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
clearpointneuro.com

52-Week Data

52-Week High:
19.22
52-Week Low:
5.11

Prediction Charts

Market Cap:
361.7M
Price in USD:
13.09
Volume:
313.8K
Beta:
1.04

Technical Analysis

SMA50:
15.60
SMA100:
14.67
SMA200:
12.12
52-Wk Change:
94.5%

Stock Predictions

  • Is ClearPoint Neuro stock public?
    Yes, ClearPoint Neuro is a publicly traded company.
  • What is the ClearPoint Neuro stock quote today?
    The ClearPoint Neuro stock price is 13.09 USD today.
  • How to buy ClearPoint Neuro stock online?
    You can buy ClearPoint Neuro shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-13 13.16 12.56 13.60 12.43
Mar-14 12.80 12.81 13.21 12.48
Mar-17 12.80 13.60 13.77 12.80
Mar-18 13.60 13.27 13.65 13.06
Mar-19 13.26 13.38 13.58 13.13
Mar-20 13.17 13.67 13.82 13.17
Mar-21 13.38 13.36 13.60 13.09
Mar-24 13.76 13.78 14.01 13.70
Mar-25 13.75 13.17 13.75 13.08
Mar-26 13.12 12.46 13.17 12.42
Mar-27 12.73 12.42 12.73 12.30
Mar-28 12.33 11.97 12.35 11.72
Mar-31 11.61 11.90 12.06 11.32
Apr-1 12.17 13.09 13.20 12.02

ClearPoint Neuro Earnings

ClearPoint Neuro Earnings Report: Per Share ClearPoint Neuro Earnings Q1 Q2 Q3 and Q4 last year and next year.

ClearPoint Neuro Forecast Revenue Growth

ClearPoint Neuro Stock Analysis: Historical quarterly revenues per share for ClearPoint Neuro and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and a decrease next year of $0.00 per share.

* ClearPoint Neuro stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.